{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:39:29Z","timestamp":1792175969256,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102469"],"award-info":[{"award-number":["82102469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Imbalanced immune responses are involved in developing preeclampsia (PE). We wish to explore the expression and potential changes of immune checkpoint molecules TIGIT, CD226 and CD155 in PE patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of the immune checkpoint molecules TIGIT, CD226 and CD155 in different lymphocyte subpopulations was determined by flow cytometry in 24 patients with PE and compared to 24 healthy pregnant women of the same gestational age as the controls.\u200bSerum CD155 was detected by ELISA in the patients with PE compared to controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The percentages of CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T lymphocytes in the peripheral blood of PE patients were not significantly different from those of the controls, whereas the regulatory T cells (Tregs) in PE patients were significantly lower than those in controls (6.43\u2009\u00b1\u20091.77% vs. 7.48\u2009\u00b1\u20091.71%, <jats:italic>P<\/jats:italic>\u2009=\u20090.0420). The expression of TIGIT and CD226 showed different percentages on CD4<jats:sup>+<\/jats:sup> T cells, CD8<jats:sup>+<\/jats:sup> T cells and Treg cells. However, the difference in the percentages of TIGIT, CD226 on these T cells between the two groups was not statistically significant. The level of CD155 in peripheral serum of PE patients was 6.64\u2009\u00b1\u20091.79 ng\/ml, which was not significantly different from that in the control group 5.61\u2009\u00b1\u20091.77 ng\/ml, <jats:italic>P<\/jats:italic>\u2009=\u20090.0505. The present results demonstrate that TIGIT, CD226 and CD155 are not present at altered immune conditions in the peripheral blood of patients with PE, compared with normal pregnant women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The immune checkpoint molecules TIGIT, CD226 and CD155 are not abnormally expressed in PE patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12865-024-00603-5","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T11:02:22Z","timestamp":1707303742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Cui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.annepidem.2016.09.015","volume":"26","author":"KM Baca","year":"2016","unstructured":"Baca KM, Simhan HN, Platt RW, Bodnar LM. Low maternal 25-hydroxyvitamin D concentration increases the risk of severe and mild preeclampsia. Ann Epidemiol. 2016;26:853\u2013857e1.","journal-title":"Ann Epidemiol"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12011-013-9637-4","volume":"152","author":"T Ahsan","year":"2013","unstructured":"Ahsan T, Banu S, Nahar Q, Ahsan M, Khan MN, Islam SN. Serum trace elements levels in preeclampsia and eclampsia: correlation with the pregnancy disorder. Biol Trace Elem Res. 2013;152:327\u201332.","journal-title":"Biol Trace Elem Res"},{"key":"603_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jri.2013.09.001","volume":"101\u2013102","author":"AC Staff","year":"2014","unstructured":"Staff AC, Johnsen GM, Dechend R, Redman C. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol. 2014;101\u2013102:120\u20136.","journal-title":"J Reprod Immunol"},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","volume":"77","author":"W He","year":"2017","unstructured":"He W, Zhang H, Han F, Chen X, Lin R, Wang W, Qiu H, Zhuang Z, Liao Q, Zhang W, et al. CD155T\/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes Tumor Progression in Human gastric Cancer. Cancer Res. 2017;77:6375\u201388.","journal-title":"Cancer Res"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.4049\/jimmunol.1501591","volume":"196","author":"E Kourepini","year":"2016","unstructured":"Kourepini E, Paschalidis N, Simoes DC, Aggelakopoulou M, Grogan JL, Panoutsakopoulou V. TIGIT enhances Antigen-Specific Th2 recall responses and allergic disease. J Immunol. 2016;196:3570\u201380.","journal-title":"J Immunol"},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molimm.2015.11.009","volume":"69","author":"AV Vo","year":"2016","unstructured":"Vo AV, Takenaka E, Shibuya A, Shibuya K. Expression of DNAM-1 (CD226) on inflammatory monocytes. Mol Immunol. 2016;69:70\u20136.","journal-title":"Mol Immunol"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","volume":"188","author":"E Lozano","year":"2012","unstructured":"Lozano E, Dominguez-Villar M, Kuchroo V, Hafler DA. The TIGIT\/CD226 axis regulates human T cell function. J Immunol. 2012;188:3869\u201375.","journal-title":"J Immunol"},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2013.12.011","volume":"40","author":"T Nabekura","year":"2014","unstructured":"Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne NR, Lanier LL. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity. 2014;40:225\u201334.","journal-title":"Immunity"},{"key":"603_CR9","doi-asserted-by":"crossref","unstructured":"Meggyes M, Nagy DU, Feik T, Boros A, Polgar B, Szereday L. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a healthy pregnancy. Int J Mol Sci 2022, 23.","DOI":"10.3390\/ijms231810776"},{"key":"603_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1084\/jem.20030788","volume":"198","author":"C Bottino","year":"2003","unstructured":"Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med. 2003;198:557\u201367.","journal-title":"J Exp Med"},{"key":"603_CR11","doi-asserted-by":"crossref","unstructured":"Lee BH, Kim JH, Kang KW, Lee SR, Park Y, Sung HJ, Kim BS. PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma. Biomedicines 2022, 10.","DOI":"10.21203\/rs.3.rs-1463725\/v1"},{"key":"603_CR12","doi-asserted-by":"publisher","first-page":"e24259","DOI":"10.1002\/jcla.24259","volume":"36","author":"AL Jin","year":"2022","unstructured":"Jin AL, Yang YH, Su X, Yang WJ, Liu T, Chen W, Li T, Ding L, Wang H, Wang BL, et al. High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma. J Clin Lab Anal. 2022;36:e24259.","journal-title":"J Clin Lab Anal"},{"key":"603_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-021-00741-9","volume":"22","author":"MO Azzazi","year":"2022","unstructured":"Azzazi MO, Hegab HM, El-Ghammaz A, Saber HM, Afifi YA. Impact of serum soluble CD155 level at diagnosis on interim response to CHOP with or without rituximab in diffuse large B cell lymphoma. Clin Exp Med. 2022;22:173\u201381.","journal-title":"Clin Exp Med"},{"key":"603_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/RD9.0000000000000032","volume":"6","author":"C Li","year":"2022","unstructured":"Li C, Ying C, Duan Z. The imbalance of T-cell immunoglobulin and ITIM domain and CD226 on regulatory T cell in recurrent spontaneous abortion patients. Reproductive Dev Med. 2022;6:175\u201380.","journal-title":"Reproductive Dev Med"},{"key":"603_CR15","doi-asserted-by":"crossref","unstructured":"Molfetta R, Zitti B, Lecce M, Milito ND, Stabile H, Fionda C, Cippitelli M, Gismondi A, Santoni A, Paolini R. CD155: a multi-functional molecule in Tumor Progression. Int J Mol Sci 2020, 21.","DOI":"10.3390\/ijms21030922"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2019.11.013","volume":"65","author":"J JS O\u2019Donnell","year":"2020","unstructured":"JS O\u2019Donnell J, Madore XY, Li MJ, Smyth. Tumor intrinsic and extrinsic immune functions of CD155. Semin Cancer Biol. 2020;65:189\u201396.","journal-title":"Semin Cancer Biol"},{"key":"603_CR17","doi-asserted-by":"crossref","unstructured":"Robertson SA, Green ES, Care AS, Moldenhauer LM, Prins JR, Hull ML, Barry SC. G Dekker: Therapeutic Potential of Regulatory T Cells in Preeclampsia-Opportunities and Challenges. Front Immunol 2019, 10:478.","DOI":"10.3389\/fimmu.2019.00478"},{"key":"603_CR18","doi-asserted-by":"crossref","unstructured":"Szereday L, Nagy DU, Csiszar B, Kevey D, Feik T, Meggyes M. Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint molecules in Peripheral Blood mononuclear cells in women diagnosed with early-onset Preeclampsia. Biomedicines 2021, 9.","DOI":"10.3390\/biomedicines9111608"},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1038\/s41467-019-10703-1","volume":"10","author":"M Hu","year":"2019","unstructured":"Hu M, Eviston D, Hsu P, Marino E, Chidgey A, Santner-Nanan B, Wong K, Richards JL, Yap YA, Collier F, et al. Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia. Nat Commun. 2019;10:3031.","journal-title":"Nat Commun"},{"key":"603_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jri.2019.06.002","volume":"133","author":"M Zare","year":"2019","unstructured":"Zare M, Namavar JB, Gharesi-Fard B. Analysis of the frequencies and functions of CD4(+)CD25(+)CD127(low\/neg), CD4(+)HLA-G(+), and CD8(+)HLA-G(+) regulatory T cells in pre-eclampsia. J Reprod Immunol. 2019;133:43\u201351.","journal-title":"J Reprod Immunol"},{"key":"603_CR21","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.jaut.2020.102485","volume":"113","author":"C Deng","year":"2020","unstructured":"Deng C, Chen Y, Li W, Peng L, Luo X, Peng Y, Zhao L, Wu Q, Zhang W, Zhang X, et al. Alteration of CD226\/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjogren\u2019s syndrome. J Autoimmun. 2020;113:102485.","journal-title":"J Autoimmun"},{"key":"603_CR22","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1002\/eji.201243072","volume":"43","author":"N Stanietsky","year":"2013","unstructured":"Stanietsky N, Rovis TL, Glasner A, Seidel E, Tsukerman P, Yamin R, Enk J, Jonjic S, Mandelboim O. Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR. Eur J Immunol. 2013;43:2138\u201350.","journal-title":"Eur J Immunol"},{"key":"603_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","volume":"10","author":"X Yu","year":"2009","unstructured":"Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, Tom I, Ivelja S, Refino CJ, Clark H, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10:48\u201357.","journal-title":"Nat Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-024-00603-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T11:04:06Z","timestamp":1707303846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-024-00603-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1186\/s12865-024-00603-5","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human bleed and human data in this study have been performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Obstetrics and Gynecology Hospital of Fudan University (no. 2021\u2009\u2212\u2009214). Informed consents were written by participants in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}